Zohydro Abuse-Deterrent Version May Hit Market Faster, Minus Strong Label
This article was originally published in The Pink Sheet Daily
Executive Summary
Under pressure from legislators, Zogenix plans to get new version of Zohydro ER that is harder to abuse to market by early 2015, even if won’t have a full set of FDA-approved claims.